Tang Zy
About
In The Last Decade
Tang Zy
47 papers receiving 612 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 228
- Hepatology 213
- Cancer Research 172
- Oncology 154
- Epidemiology 131
Countries citing papers authored by Tang Zy
This map shows the geographic impact of Tang Zy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tang Zy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tang Zy more than expected).
Fields of papers citing papers by Tang Zy
This network shows the impact of papers produced by Tang Zy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tang Zy. The network helps show where Tang Zy may publish in the future.
Co-authorship network of co-authors of Tang Zy
This figure shows the co-authorship network connecting the top 25 collaborators of Tang Zy. A scholar is included among the top collaborators of Tang Zy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tang Zy. Tang Zy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 40 | |
| 2 | 58 | |
| 3 | Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. | 57 |
| 4 | 36 | |
| 5 | 59 | |
| 6 | 8 | |
| 7 | Facile Total Synthesis of 3-Oxo-11,12,13-trihydroxyeudesm-4-ene | 1 |
| 8 | 27 | |
| 9 | Interannual Variability in Net Primary Production and Precipitation Science | 27 |
| 10 | Effect of antiangiogenic agents on experimental animal models of hepatocellular carcinoma. | 12 |
| 11 | KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases. | 20 |
| 12 | Management of hepatocellular carcinoma: long-term outcome in 2639 cases. | 11 |
| 13 | [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma]. | 6 |
| 14 | Hepatic artery ligation and infusion chemotherapy for unresectable primary liver cancer. | 7 |
| 15 | Acquired cytomegalovirus infection of breast milk in infancy. | 4 |
| 16 | [Advances in recent clinical studies of liver cancer]. | 1 |
| 17 | An expert system designed as a tutoring tool in cervical cytology: TTCC-1 system. | 2 |
| 18 | [Small hepatocellular carcinoma (HCC) and its remote outcome]. | 2 |
| 19 | [Randomized clinical trial of cis-platinum diamminedichloride (PDD) in the treatment of hepatocellular carcinoma (HCC)]. | 0 |
| 20 | [High-power Nd:YAG laser in the treatment of liver cancer: experimental and clinical study]. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.